Advanced Medical Solutions Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Advanced Medical Solutions Group generated cash of $12,345,000, which is less than the previous year. Cash used in financing activities reached the amount of -$13,256,000 last year. Net change in cash is therefore -$22,102,000.
Cash Flow
| 2014 | 16.57M | -2.35M | -1.24M |
|---|---|---|---|
| 2015 | 21.29M | -2.60M | -1.14M |
| 2016 | 19.82M | -2.42M | -1.02M |
| 2017 | 16.96M | -4.30M | -1.35M |
| 2018 | 21.67M | -4.30M | -3.50M |
| 2019 | 21.41M | -29.99M | -2.87M |
| 2020 | 21.05M | -27.04M | -5.08M |
| 2021 | 30.40M | -6.41M | -4.40M |
| 2022 | 27.08M | -12.69M | -5.70M |
| 2023 | 12.34M | -20.26M | -13.25M |
AMS.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 82.26M | 72.96M | 53.82M | 64.75M | 76.39M | 62.45M | 51.12M | 34.20M | 17.28M | 5.25M |
Operating activities | ||||||||||
Net income | 15.88M | 20.40M | 17.48M | 8.58M | 18.91M | 22.48M | 20.13M | 15.69M | 14.11M | 12.86M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 10.78M | 8.84M | 8.84M | 6.83M | 5.84M | 3.26M | 2.18M | 2.14M | 2.11M | 2.13M |
Stock-based compensation expense | 2.91M | 2.43M | 1.97M | 1.61M | 1.85M | 1.65M | 1.27M | 1.23M | 709K | 592K |
| Deferred income tax benefit | 2.91M | 2.43M | 1.97M | 1.61M | 1.85M | 1.65M | 1.27M | 1.23M | 709K | 592K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -2.51M | -596K | -1.76M | 10.26M | -574K | -6.81M | -8.62M | -674K | 2.14M | -1.62M |
Inventories | -8.06M | -7.08M | 941K | -1.89M | -2.45M | -3.70M | 505K | -2.00M | -1.50M | 221K |
Accounts payable | -5.24M | 1.71M | 2.10M | -2.29M | -1.27M | 1.69M | 73K | 1.19M | 1.33M | 0 |
Cash generated by operating activities | 12.34M | 27.08M | 30.40M | 21.05M | 21.41M | 21.67M | 16.96M | 19.82M | 21.29M | 16.57M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -3.54M | -9.96M | -6.46M | -5.26M | -5.85M | -3.06M | -2.90M | -1.52M | -1.90M | -1.47M |
Acquisitions Net | -12.92M | -2.73M | 53K | -21.78M | -24.14M | 78K | 264K | 41K | 77K | 0 |
Cash generated by investing activities | -20.26M | -12.69M | -6.41M | -27.04M | -29.99M | -4.30M | -4.30M | -2.42M | -2.60M | -2.35M |
Financing activities | ||||||||||
Common Stock Issued | 181K | 655K | 1.08M | 604K | 1.66M | 1.02M | 1.29M | 1.31M | 756K | 65K |
Payments for dividends | -4.77M | -4.34M | -3.84M | -3.33M | -3.00M | -2.49M | -2.04M | -1.78M | -1.52M | -1.30M |
Repurchases of common stock | -6.71M | -392K | -366K | -542K | -603K | -600K | -484K | -449K | -262K | -190K |
Repayments of term debt | -480K | -331K | -1.28M | -664K | 0 | -858K | 0 | -1K | 0 | -4K |
Cash used in financing activities | -13.25M | -5.70M | -4.40M | -5.08M | -2.87M | -3.50M | -1.35M | -1.02M | -1.14M | -1.24M |
Net Change In Cash | -22.10M | 9.29M | 19.13M | -10.92M | -11.64M | 13.93M | 11.32M | 16.92M | 16.92M | 12.02M |
Cash at end of period | 60.16M | 82.26M | 72.96M | 53.82M | 64.75M | 76.39M | 62.45M | 51.12M | 34.20M | 17.28M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |